The Impact of COVID-19 on Oral Cancer Diagnosis: A Systematic Review

Authors

  • Riccardo Pulcini Department of Innovative Technologies in Medicine & Dentistry, University G. d'Annunzio, Chieti-65013 (Italy) https://orcid.org/0000-0001-8334-0577
  • Silvia D'Agostino Department of Innovative Technologies in Medicine & Dentistry, University G. d'Annunzio, Chieti-65013 (Italy) https://orcid.org/0000-0002-4778-4768
  • Marco Dolci Department of Innovative Technologies in Medicine & Dentistry, University G. d'Annunzio, Chieti-65013 (Italy) https://orcid.org/0000-0001-5495-5660
  • Alessandra Bissioli Department of Innovative Technologies in Medicine & Dentistry, University G. d'Annunzio, Chieti-65013 (Italy)
  • Lucia Caporaso Department of Innovative Technologies in Medicine & Dentistry, University G. d'Annunzio, Chieti-65013 (Italy)
  • Francesca Iarussi Department of Innovative Technologies in Medicine & Dentistry, University G. d'Annunzio, Chieti-65013 (Italy)

DOI:

https://doi.org/10.47352/jmans.2774-3047.110

Keywords:

COVID-19, Sars-Cov-2, oral cancer, oral squamous cell carcinoma, public health

Abstract

The Coronavirus-19 pandemic has led to severe collapses in international health systems that have repercussions at all levels of disease prevention. Oral squamous cell carcinoma (OSCC) is the most common head / neck malignancy, and it is usually diagnosed late due to patients neglecting symptoms. The purpose of this systematic review is to verify the impact of Sars-Cov-2 pandemic on OSCC diagnosis. The search methodology follows the PRISMA statement performing a PubMed investigation from 2019 to 2021 using MeSH such as “Covid-19; oral cancer”. A multidisciplinary approach would be effective, with a broadening of the knowledge of health professionals to identify cancerous lesions. A timely diagnosis of OSCC is crucial and its management is fundamental also for dental specialists. With the aim to anticipate the diagnosis, it will be desirable to set prevention campaigns also by the assistance in telemedicine.

References

[1] Y. Shi, Y. Wang, C. Shao, J. Huang, J. Gan, X. Huang, E. Bucci, M. Piacentini, G. Ippolito, and G. Melino. (2020). “COVID-19 infection: the perspectives on immune responses”. Cell Death & Differentiation. 27 (5): 1451–1454. 10.1038/s41418-020-0530-3.

[2] D. A. Berlin, R. M. Gulick, and F. J. Martinez. (2020). “Severe Covid-19”. New England Journal of Medicine. 383 (25): 2451–2460. 10.1056/NEJMcp2009575.

[3] A. Sud, B. Torr, M. E. Jones, J. Broggio, S. Scott, C. Loveday, A. Garrett, F. Gronthoud, D. L. Nicol, S. Jhanji, S. A. Boyce, M. Williams, E. Riboli, D. C. Muller, E. Kipps, J. Larkin, N. Navani, C. Swanton, G. Lyratzopoulos, E. McFerran, M. Lawler, R. Houlston, and C. Turnbull. (2020). “Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study”. The Lancet Oncology. 21 (8): 1035–1044. 10.1016/S1470-2045(20)30392-2.

[4] S. M. Akula, S. L. Abrams, L. S. Steelman, S. Candido, M. Libra, K. Lerpiriyapong, L. Cocco, G. Ramazzotti, S. Ratti, M. Y. Follo, A. M. Martelli, W. L. Blalock, M. Piazzi, G. Montalto, M. Cervello, M. Notarbartolo, J. Basecke, and J. A. McCubrey. (2020). “Cancer therapy and treatments during COVID-19 era”. Advances in Biological Regulation. 77. 100739. 10.1016/j.jbior.2020.100739.

[5] L. Caporaso, A. Bissoli, F. Iarussi, R. Pulcini, M. Dolci, and S. D’Agostino. (2022). “The Importance of The Dental Hygienist in Implantology: A Narrative Review”. Journal of Multidisciplinary Applied Natural Science. 2 (1): 19–22. 10.47352/jmans.2774-3047.94.

[6] S. Yost, P. Stashenko, Y. Choi, M. Kukuruzinska, C. A. Genco, A. Salama, E. O. Weinberg, C. D. Kramer, and J. Frias-Lopez. (2018). “Increased virulence of the oral microbiome in oral squamous cell carcinoma revealed by metatranscriptome analyses”. International Journal of Oral Science. 10 (4): 32. 10.1038/s41368-018-0037-7.

[7] P. Gholizadeh, H. Eslami, M. Yousefi, M. Asgharzadeh, M. Aghazadeh, and H. S. Kafil. (2016). “Role of oral microbiome on oral cancers, a review”. Biomedicine & Pharmacotherapy. 84 : 552–558. 10.1016/j.biopha.2016.09.082.

[8] J. Ferlay, M. Colombet, I. Soerjomataram, C. Mathers, D. M. Parkin, M. Piñeros, A. Znaor, and F. Bray. (2019). “Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods”. International Journal of Cancer. 144 (8): 1941–1953. 10.1002/ijc.31937.

[9] D. E. Morse, W. J. Psoter, D. Cleveland, D. Cohen, M. Mohit-Tabatabai, D. L. Kosis, and E. Eisenberg. (2007). “Smoking and drinking in relation to oral cancer and oral epithelial dysplasia”. Cancer Causes & Control. 18 (9): 919–929. 10.1007/s10552-007-9026-4.

[10] M. Kumar, R. Nanavati, T. Modi, and C. Dobariya. (2016). “Oral cancer: Etiology and risk factors: A review”. Journal of Cancer Research and Therapeutics. 12 (2): 458. 10.4103/0973-1482.186696.

[11] P. H. Montero and S. G. Patel. (2015). “Cancer of the Oral Cavity”. Surgical Oncology Clinics of North America. 24 (3): 491–508. 10.1016/j.soc.2015.03.006.

[12] M. L. Gillison. (2007). “Current topics in the epidemiology of oral cavity and oropharyngeal cancers”. Head & Neck. 29 (8): 779–792. 10.1002/hed.20573.

[13] S. Scott, M. McGurk, and E. Grunfeld. (2008). “Patient delay for potentially malignant oral symptoms”. European Journal of Oral Sciences. 116 (2): 141–147. 10.1111/j.1600-0722.2007.00520.x.

[14] S. D’souza and V. Addepalli. (2018). “Preventive measures in oral cancer: An overview”. Biomedicine and Pharmacotherapy. 107 : 72–80. 10.1016/j.biopha.2018.07.114.

[15] D. E. da Cruz Perez, K. K. M. Passos, R. A. Machado, H. Martelli-Junior, and P. R. F. Bonan. (2020). “Continuing education in oral cancer during coronavirus disease 2019 (covid-19) outbreak.” Oral Oncology. 105 : 104713. 10.1016/j.oraloncology.2020.104713.

[16] M. J. Page, J. E. McKenzie, P. M. Bossuyt, I. Boutron, T. C. Hoffmann, C. D. Mulrow, L. Shamseer, J. M. Tetzlaff, E. A. Akl, S. E. Brennan, R. Chou, J. Glanville, J. M. Grimshaw, A. Hróbjartsson, M. M. Lalu, T. Li, E. W. Loder, E.  Mayo-Wilson, S. McDonald, L. A. McGuinness, L. A. Stewart, J. Thomas, A. C. Tricco, V. A. Welch, P. Whiting, and D. Moher. (2021). “The PRISMA 2020 statement: an updated guideline for reporting systematic reviews”. BMJ. n71. 10.1136/bmj.n71.

[17] F. A. Villani, R. Aiuto, L. Paglia, and D. Re. (2020). “COVID-19 and Dentistry: Prevention in Dental Practice, a Literature Review”. International Journal of Environmental Research and Public Health. 17 (12): 4609. 10.3390/ijerph17124609.

[18] A. T. Day, D. J. Sher, R. C. Lee, J. M. Truelson, L. L. Myers, B. D. Sumer, L. Stankova, B. N. Tillman, R. S. Hughes, S. A. Khan, and E. A. Gordin. (2020). “Head and neck oncology during the COVID-19 pandemic: Reconsidering traditional treatment paradigms in light of new surgical and other multilevel risks.” Oral Oncology. 105 : 104684. 10.1016/j.oraloncology.2020.104684.

[19] K. Søreide, J. Hallet, J. B. Matthews, A. A. Schnitzbauer, P. D. Line, P. B. S. Lai, J. Otero, D. Callegaro, S. G. Warner, N. N. Baxter, C. S. C. Teh, J. Ng-Kamstra, J. G. Meara, L. Hagander, and L. Lorenzon. (2020). “Immediate and long-term impact of the COVID-19 pandemic on delivery of surgical services”. British Journal of Surgery. 107 (10): 1250–1261. 10.1002/bjs.11670.

[20] M. Ferrari, A. Paderno, L. Giannini, D. Cazzador, C. Ciardiello, G. Carretta, C. Piazza, and P. Nicolai. (2021). “COVID-19 screening protocols for preoperative assessment of head and neck cancer patients candidate for elective surgery in the midst of the pandemic: A narrative review with comparison between two Italian institutions”. Oral Oncology. 112 : 105043. 10.1016/j.oraloncology.2020.105043.

Downloads

Published

2022-04-04

How to Cite

[1]
R. Pulcini, S. D’Agostino, M. Dolci, A. Bissioli, L. Caporaso, and F. Iarussi, “The Impact of COVID-19 on Oral Cancer Diagnosis: A Systematic Review”, J. Multidiscip. Appl. Nat. Sci., vol. 2, no. 2, pp. 65-69, Apr. 2022.